Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 1
1984 4
1985 2
1986 6
1987 4
1988 4
1989 6
1990 6
1991 8
1992 13
1993 10
1994 13
1995 10
1996 4
1997 13
1998 11
1999 14
2000 7
2001 11
2002 6
2003 10
2004 9
2005 10
2006 5
2007 13
2008 9
2009 9
2010 20
2011 16
2012 11
2013 9
2014 12
2015 10
2016 16
2017 14
2018 12
2019 8
2020 8
2021 10
2022 13
2023 16
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

362 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Desmopressin for treating nocturia in men.
Han J, Jung JH, Bakker CJ, Ebell MH, Dahm P. Han J, et al. Cochrane Database Syst Rev. 2017 Oct 21;10(10):CD012059. doi: 10.1002/14651858.CD012059.pub2. Cochrane Database Syst Rev. 2017. PMID: 29055129 Free PMC article. Review.
BACKGROUND: Nocturia is the bothersome symptom of awakening one or more times per night to void. Desmopressin is a commonly used medication for treating nocturia. OBJECTIVES: To assess the effects of desmopressin as compared to other interventions in the treatment o …
BACKGROUND: Nocturia is the bothersome symptom of awakening one or more times per night to void. Desmopressin is a commonly used medi …
Desmopressin for patients with spontaneous intracerebral haemorrhage taking antiplatelet drugs (DASH): a UK-based, phase 2, randomised, placebo-controlled, multicentre feasibility trial.
Desborough MJR, Al-Shahi Salman R, Stanworth SJ, Havard D, Woodhouse LJ, Craig J, Krishnan K, Brennan PM, Dineen RA, Coats TJ, Hepburn T, Bath PM, Sprigg N; DASH trial investigators. Desborough MJR, et al. Lancet Neurol. 2023 Jul;22(7):557-567. doi: 10.1016/S1474-4422(23)00157-6. Lancet Neurol. 2023. PMID: 37353276 Free PMC article. Clinical Trial.
Serious adverse events occurred in 12 (44%) participants in the desmopressin group and 13 (48%) participants in the placebo group. The most common adverse events were expansion of the haemorrhagic stroke (four [15%] of 27 participants in the desmopressin group and s …
Serious adverse events occurred in 12 (44%) participants in the desmopressin group and 13 (48%) participants in the placebo group. Th …
Desmopressin Withdrawal Strategy for Pediatric Enuresis: A Meta-analysis.
Chua ME, Silangcruz JM, Chang SJ, Williams K, Saunders M, Lopes RI, Farhat WA, Yang SS. Chua ME, et al. Pediatrics. 2016 Jul;138(1):e20160495. doi: 10.1542/peds.2016-0495. Epub 2016 Jun 24. Pediatrics. 2016. PMID: 27343233 Review.
CONTEXT: A high relapse rate after discontinuation of desmopressin treatment of pediatric enuresis is consistently reported. ...OBJECTIVE: To assess the efficacy of a structured withdrawal strategy of desmopressin on the relapse-free rate for desmopressin res …
CONTEXT: A high relapse rate after discontinuation of desmopressin treatment of pediatric enuresis is consistently reported. ...OBJEC …
Desmopressin effectiveness in renal colic pain management: Systematic review and meta-analysis.
Jalili M, Entezari P, Doosti-Irani A, Masoomi R, Mirfazaelian H. Jalili M, et al. Am J Emerg Med. 2016 Aug;34(8):1535-41. doi: 10.1016/j.ajem.2016.05.020. Epub 2016 May 12. Am J Emerg Med. 2016. PMID: 27289437 Review.
Summary of relative risk (RR) for the need for rescue treatment in desmopressin in comparison to NSAID was 0.31 with a 95% CI of 0.13-0.74 and a significant RR (P<.04), but no difference was shown in desmopressin-NSAID combination in comparison to NSAID (0.70 wit …
Summary of relative risk (RR) for the need for rescue treatment in desmopressin in comparison to NSAID was 0.31 with a 95% CI of 0.13 …
Desmopressin use for minimising perioperative blood transfusion.
Desborough MJ, Oakland K, Brierley C, Bennett S, Doree C, Trivella M, Hopewell S, Stanworth SJ, Estcourt LJ. Desborough MJ, et al. Cochrane Database Syst Rev. 2017 Jul 10;7(7):CD001884. doi: 10.1002/14651858.CD001884.pub3. Cochrane Database Syst Rev. 2017. PMID: 28691229 Free PMC article. Review.
BACKGROUND: Blood transfusion is administered during many types of surgery, but its efficacy and safety are increasingly questioned. Evaluation of the efficacy of agents, such as desmopressin (DDAVP; 1-deamino-8-D-arginine-vasopressin), that may reduce …
BACKGROUND: Blood transfusion is administered during many types of surgery, but its efficacy and safety are increasingly questioned. Evaluat …
Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: a systematic review and meta-analysis of randomized controlled trials.
Desborough MJ, Oakland KA, Landoni G, Crivellari M, Doree C, Estcourt LJ, Stanworth SJ. Desborough MJ, et al. J Thromb Haemost. 2017 Feb;15(2):263-272. doi: 10.1111/jth.13576. Epub 2017 Feb 8. J Thromb Haemost. 2017. PMID: 27893176 Free article. Review.
This meta-analysis compared perioperative administration of desmopressin to placebo. Desmopressin reduced red cell transfusions, blood loss and risk of re-operation due to bleeding. ...The optimal management of patients with platelet dysfunction undergoing surgery i …
This meta-analysis compared perioperative administration of desmopressin to placebo. Desmopressin reduced red cell transfusion …
The efficacy and safety of desmopressin acetate applied for nocturia in benign prostatic hyperplasia patients: A systematic review and meta-analysis.
Wang Q, Alshayyah R, Yang B. Wang Q, et al. Low Urin Tract Symptoms. 2022 May;14(3):155-162. doi: 10.1111/luts.12423. Epub 2022 Jan 16. Low Urin Tract Symptoms. 2022. PMID: 35034423 Review.
CONCLUSION: Desmopressin acetate can reduce nocturia frequency and improve the IPSS-S and QoL score in BPH patients. ...No significant difference of desmopressin was found in improving the overall IPSS score and maximum urine flow....
CONCLUSION: Desmopressin acetate can reduce nocturia frequency and improve the IPSS-S and QoL score in BPH patients. ...No significan …
Efficacy of prophylactic pre-operative desmopressin administration during functional endoscopic sinus surgery for chronic rhinosinusitis: A systematic review and meta-analysis of randomised placebo-controlled trials.
Alrajhi AA, Alghamdi AS, Baali MH, Altowairqi AF, Khan MF, Alharthi AS, Albazee E, Abu-Zaid A. Alrajhi AA, et al. Clin Otolaryngol. 2023 Mar;48(2):139-150. doi: 10.1111/coa.14020. Epub 2023 Jan 3. Clin Otolaryngol. 2023. PMID: 36536598 Review.
OBJECTIVES: To examine the efficacy of prophylactic desmopressin versus placebo among patients undergoing functional endoscopic sinus surgery (FESS). ...CONCLUSIONS: Among patients undergoing FESS, prophylactic administration of desmopressin does not correlate with …
OBJECTIVES: To examine the efficacy of prophylactic desmopressin versus placebo among patients undergoing functional endoscopic sinus …
Efficacy and safety of desmopressin in nocturia and nocturnal polyuria control of neurological patients: A systematic review and meta-analysis.
Hajebrahimi S, Darvishi A, HajEbrahimi R, Asadi N, Jafari Shendi Z, Asiaban N, Naseri A, Sadeghi-Ghyassi F, Mostafaei H, Salehi-Pourmehr H. Hajebrahimi S, et al. Neurourol Urodyn. 2024 Jan;43(1):167-182. doi: 10.1002/nau.25291. Epub 2023 Sep 25. Neurourol Urodyn. 2024. PMID: 37746880 Review.
Studies were considered if they provided information on the effectiveness and safety of desmopressin (1-desamino-8-d-arginine vasopressin, or DDAVP) in the treatment of nocturia and their participants had acquired neurological pathology. ...Thirteen studies e …
Studies were considered if they provided information on the effectiveness and safety of desmopressin (1-desamino-8-d-arginine …
Desmopressin for treating nocturia in men.
Han J, Jung JH, Bakker CJ, Ebell MH, Dahm P. Han J, et al. BJU Int. 2018 Oct;122(4):549-559. doi: 10.1111/bju.14183. Epub 2018 Mar 26. BJU Int. 2018. PMID: 29489052
OBJECTIVES: To assess the effects of desmopressin as compared to other interventions in the treatment of nocturia in men. ...Desmopressin vs placebo: based on short-term follow-up (3 months), desmopressin may have a similar effect on the number of nocturnal v …
OBJECTIVES: To assess the effects of desmopressin as compared to other interventions in the treatment of nocturia in men. ...Desmo …
362 results

Searches related to "desmopressin"